COMP <GO>
USPH vs TDOC // EV/EBITDA & P/E VALUATION
U.S. Physical Therapy Inc. (NYSE) VS. Teladoc Health Inc. (NYSE) • 15-METRIC TALLY: USPH 8
— TDOC 3
■ METRIC PARITY
LAST: $84.90 (-1.08%) • MKT CAP: $1.28B
valuation
16.3x
LAST: $8.63 (+1.41%) • MKT CAP: $1.55B
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (USPH VS. TDOC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | USPH | TDOC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 19.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.50% | -17.00% | +28.50 | USPH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 16.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 5.81% | 18.00% | -12.19 | TDOC | /fcf-yield <GO> |
| Operating Margin | 11.10% | -10.40% | +21.50 | USPH | /operating-margins <GO> |
| Net Profit Margin | 5.10% | -7.90% | +13.00 | USPH | /net-margins <GO> |
| Revenue Growth (YoY) | 16.30% | -1.50% | +17.80 | USPH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.12% | 0.00% | +2.12 | USPH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.94 | 0.45 | +2.49 | USPH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | USPH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.8 | 74.1 | -22.30 | TDOC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.08 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.4x | 32.0x | -4.60 | USPH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.28B | $1.55B | -$270.5M | TDOC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | USPH REV | TDOC REV | USPH GROSS % | TDOC GROSS % | USPH FCF | TDOC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $781.0M | $2.53B | 19.2% | — | $75.1M | $285.5M |
| FY 2024 | $671.3M | $2.57B | 18.5% | — | $74.9M | $282.9M |
| FY 2023 | $604.8M | $2.60B | — | — | $82.0M | $232.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
USPH // BETA —
TDOC // BETA 1.08